デジタルバイオマーカーの世界市場成長(現状と展望)2022-2028年Global Digital Biomarker Market Growth (Status and Outlook) 2022-2028 市場の分析と洞察。デジタルバイオマーカーの世界市場 デジタルバイオマーカーの世界市場規模は、2021年の3億8724万米ドルから2028年には2億2357万91米ドルに達し、2022年から2028年の間に82.53%のCAGRで推移す... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。デジタルバイオマーカーの世界市場デジタルバイオマーカーの世界市場規模は、2021年の3億8724万米ドルから2028年には2億2357万91米ドルに達し、2022年から2028年の間に82.53%のCAGRで推移すると予測されています。 この健康危機による経済変化を十分に考慮すると、2021年にデジタルバイオマーカー世界市場の65.55%を占めたパッシブデジタルバイオマーカーは、2028年までに151億7,655万米ドルの価値を持ち、COVID-19後の期間に83.46%の修正CAGRで成長すると予測されます。一方、臨床疾患分野は、この予測期間を通してCAGR83.25%に変化しています。 中国のデジタルバイオマーカーの市場規模は2021年に2486万米ドル、北米と欧州のデジタルバイオマーカーはそれぞれ1億4096万米ドル、1億6717万米ドルとなっています。2021年の北米の割合は36.40%、中国とヨーロッパはそれぞれ6.42%と43.17%で、中国の割合は2028年には6.08%に達すると予測され、分析期間を通じてCAGR 81.11%で推移している。アジアでは日本と韓国が注目すべき市場であり、今後6年間のCAGRはそれぞれ83.99%と72.81%となる。欧州のデジタルバイオマーカーの展望としては、ドイツが2028年までに37億624万米ドルに達し、予測期間のCAGRは90.55%と予測されています。 本レポートは、業界標準の分析精度と高いデータ整合性により、世界のデジタルバイオマーカー市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界のデジタルバイオマーカー市場の全体規模(売上高)など、検証済みで信頼できる市場予測にアクセスすることができます。 全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界のデジタルバイオマーカー市場での持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のデジタルバイオマーカー市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。 世界のデジタルバイオマーカーの範囲と市場規模 デジタルバイオマーカー市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界のデジタルバイオマーカー市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までの期間において、タイプ別とアプリケーション別の収益と予測に焦点を当てています。 会社別 フィリップス ジョンソン・エンド・ジョンソン ファイザー GEヘルスケア ノバルティス アップル サノフィ グラクソ・スミスクライン バイエル メルク アボット・ラボラトリーズ 旭化成 バイオジェン コネクサーヘルス ロシュ ヒューマ・セラピューティクス タイプ別セグメント パッシブデジタルバイオマーカー アクティブデジタルバイオマーカー 用途別セグメント 臨床疾患 日々の健康 地域別 北アメリカ 米国 カナダ アジア太平洋地域 中国 日本 韓国 その他のアジア 欧州 ドイツ フランス 英国 イタリア ロシア その他の欧州地域 目次1 REPORT OVERVIEW 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1 1.2.2 Passive Digital Biomarker 2 1.2.3 Active Digital Biomarker 2 1.3 Market by Application 3 1.3.1 Global Digital Biomarker Market Share by Application: 2017 VS 2021 VS 2028 3 1.3.2 Clinical Disease 4 1.3.3 Daily Health 4 1.4 Study Objectives 4 1.5 Years Considered 5 2 GLOBAL GROWTH TRENDS 6 2.1 Global Digital Biomarker Market Perspective (2017-2028) 6 2.2 Digital Biomarker Growth Trends by Region 7 2.2.1 Digital Biomarker Market Size by Region: 2017 VS 2021 VS 2028 7 2.2.2 Digital Biomarker Historic Market Size by Region (2017-2022) 8 2.2.3 Digital Biomarker Forecasted Market Size by Region (2023-2028) 9 2.3 Digital Biomarker Market Dynamics 9 2.3.1 Digital Biomarker Industry Trends 9 2.3.2 Digital Biomarker Market Drivers 10 2.3.3 Digital Biomarker Market Challenges and Restraints 11 3 COMPETITION LANDSCAPE BY KEY PLAYERS 12 3.1 Global Top Digital Biomarker Players by Revenue 12 3.1.1 Global Top Digital Biomarker Players by Revenue (2020-2022) 12 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2020-2022) 13 3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 14 3.3 Players Covered: Ranking by Digital Biomarker Revenue 16 3.4 Global Digital Biomarker Market Concentration Ratio 17 3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI) 17 3.4.2 Global Top 3 and Top 5 Companies by Digital Biomarker Revenue in 2021 18 3.5 Digital Biomarker Key Players Head office and Area Served 18 3.6 Date of Establishment in Digital Biomarker Market 19 3.7 Mergers & Acquisitions, Expansion Plans 19 4 DIGITAL BIOMARKER BREAKDOWN DATA BY TYPE 21 4.1 Global Digital Biomarker Historic Market Size by Type (2017-2022) 21 4.2 Global Digital Biomarker Forecasted Market Size by Type (2023-2028) 21 5 DIGITAL BIOMARKER BREAKDOWN DATA BY APPLICATION 23 5.1 Global Digital Biomarker Historic Market Size by Application (2017-2022) 23 5.2 Global Digital Biomarker Forecasted Market Size by Application (2023-2028) 23 6 NORTH AMERICA 25 6.1 North America Digital Biomarker Market Size (2017-2028) 25 6.2 North America Digital Biomarker Market Size by Type 25 6.2.1 North America Digital Biomarker Market Size by Type (2017-2022) 25 6.2.2 North America Digital Biomarker Market Size by Type (2023-2028) 25 6.2.3 North America Digital Biomarker Market Share by Type (2017-2028) 26 6.3 North America Digital Biomarker Market Size by Application 26 6.3.1 North America Digital Biomarker Market Size by Application (2017-2022) 26 6.3.2 North America Digital Biomarker Market Size by Application (2023-2028) 27 6.3.3 North America Digital Biomarker Market Share by Application (2017-2028) 27 6.4 North America Digital Biomarker Market Size by Country 27 6.4.1 North America Digital Biomarker Market Size by Country (2017-2022) 27 6.4.2 North America Digital Biomarker Market Share by Country (2023-2028) 28 6.4.3 United States 29 6.4.4 Canada 29 7 EUROPE 30 7.1 Europe Digital Biomarker Market Size (2017-2028) 30 7.2 Europe Digital Biomarker Market Size by Type 30 7.2.1 Europe Digital Biomarker Market Size by Type (2017-2022) 30 7.2.2 Europe Digital Biomarker Market Size by Type (2023-2028) 30 7.2.3 Europe Digital Biomarker Market Share by Type (2017-2028) 31 7.3 Europe Digital Biomarker Market Size by Application 31 7.3.1 Europe Digital Biomarker Market Size by Application (2017-2022) 31 7.3.2 Europe Digital Biomarker Market Size by Application (2023-2028) 32 7.3.3 Europe Digital Biomarker Market Share by Application (2017-2028) 32 7.4 Europe Digital Biomarker Market Size by Country 32 7.4.1 Europe Digital Biomarker Market Size by Country (2017-2022) 32 7.4.2 Europe Digital Biomarker Market Size by Country (2023-2028) 33 7.4.3 Germany 34 7.4.4 U.K. 34 7.4.5 France 35 7.4.6 Russia 35 7.4.7 Italy 36 8 ASIA-PACIFIC 37 8.1 Asia-Pacific Digital Biomarker Market Size (2017-2028) 37 8.2 Asia-Pacific Digital Biomarker Market Size by Type 37 8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2017-2022) 37 8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2023-2028) 37 8.2.3 Asia-Pacific Digital Biomarker Market Share by Type (2017-2028) 38 8.3 Asia-Pacific Digital Biomarker Market Size by Application 38 8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2017-2022) 38 8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2023-2028) 39 8.3.3 Asia-Pacific Digital Biomarker Market Share by Application (2017-2028) 39 8.4 Asia-Pacific Digital Biomarker Market Size by Region 39 8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2017-2022) 39 8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2023-2028) 40 8.4.3 China 41 8.4.4 Japan 41 8.4.5 South Korea 42 9 KEY PLAYERS PROFILES 43 9.1 Philips 43 9.1.1 Philips Company Details 43 9.1.2 Philips Business Overview 43 9.1.3 Philips Digital Biomarker Introduction 44 9.1.4 Philips Revenue in Digital Biomarker Business (2020-2022) 44 9.1.5 Philips Recent Development 45 9.2 Johnson & Johnson 46 9.2.1 Johnson & Johnson Company Details 46 9.2.2 Johnson & Johnson Business Overview 46 9.2.3 Johnson & Johnson Digital Biomarker Introduction 47 9.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2020-2022) 47 9.2.5 Johnson & Johnson Recent Development 47 9.3 Pfizer 48 9.3.1 Pfizer Company Details 48 9.3.2 Pfizer Business Overview 48 9.3.3 Pfizer Digital Biomarker Introduction 49 9.3.4 Pfizer Revenue in Digital Biomarker Business (2020-2022) 49 9.3.5 Pfizer Recent Development 49 9.4 GE Healthcare 50 9.4.1 GE Healthcare Company Details 50 9.4.2 GE Healthcare Business Overview 50 9.4.3 GE Healthcare Digital Biomarker Introduction 50 9.4.4 GE Healthcare Revenue in Digital Biomarker Business (2020-2022) 51 9.4.5 GE Healthcare Recent Development 51 9.5 Novartis 52 9.5.1 Novartis Company Details 52 9.5.2 Novartis Business Overview 52 9.5.3 Novartis Digital Biomarker Introduction 53 9.5.4 Novartis Revenue in Digital Biomarker Business (2020-2022) 53 9.5.5 Novartis Recent Development 53 9.6 Apple 54 9.6.1 Apple Company Details 54 9.6.2 Apple Business Overview 55 9.6.3 Apple Digital Biomarker Introduction 55 9.6.4 Apple Revenue in Digital Biomarker Business (2020-2022) 55 9.7 Sanofi 56 9.7.1 Sanofi Company Details 56 9.7.2 Sanofi Business Overview 56 9.7.3 Sanofi Digital Biomarker Introduction 57 9.7.4 Sanofi Revenue in Digital Biomarker Business (2020-2022) 57 9.8 GlaxoSmithKline 57 9.8.1 GlaxoSmithKline Company Details 57 9.8.2 GlaxoSmithKline Business Overview 58 9.8.3 GlaxoSmithKline Digital Biomarker Introduction 58 9.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2020-2022) 58 9.8.5 GlaxoSmithKline Recent Development 59 9.9 Bayer 59 9.9.1 Bayer Company Details 59 9.9.2 Bayer Business Overview 60 9.9.3 Bayer Digital Biomarker Introduction 60 9.9.4 Bayer Revenue in Digital Biomarker Business (2020-2022) 60 9.9.5 Bayer Recent Development 61 9.10 Merck 61 9.10.1 Merck Company Details 61 9.10.2 Merck Business Overview 62 9.10.3 Merck Digital Biomarker Introduction 62 9.10.4 Merck Revenue in Digital Biomarker Business (2020-2022) 62 9.10.5 Merck Recent Development 63 9.11 Abbott Laboratories 63 9.11.1 Abbott Laboratories Company Details 64 9.11.2 Abbott Laboratories Business Overview 64 9.11.3 Abbott Laboratories Digital Biomarker Introduction 65 9.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2020-2022) 65 9.11.5 Abbott Laboratories Recent Development 65 9.12 Asahi Kasei 66 9.12.1 Asahi Kasei Company Details 66 9.12.2 Asahi Kasei Business Overview 66 9.12.3 Asahi Kasei Digital Biomarker Introduction 67 9.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2020-2022) 67 9.12.5 Asahi Kasei Recent Development 67 9.13 Biogen 68 9.13.1 Biogen Company Details 68 9.13.2 Biogen Business Overview 68 9.13.3 Biogen Digital Biomarker Introduction 69 9.13.4 Biogen Revenue in Digital Biomarker Business (2020-2022) 69 9.14 Koneksa Health 69 9.14.1 Koneksa Health Company Details 70 9.14.2 Koneksa Health Business Overview 70 9.14.3 Koneksa Health Digital Biomarker Introduction 70 9.14.4 Koneksa Health Revenue in Digital Biomarker Business (2020-2022) 71 9.14.5 Koneksa Health Recent Development 71 9.15 Roche 72 9.15.1 Roche Company Details 72 9.15.2 Roche Business Overview 72 9.15.3 Roche Digital Biomarker Introduction 73 9.15.4 Roche Revenue in Digital Biomarker Business (2020-2022) 73 9.16 Huma Therapeutics 73 9.16.1 Huma Therapeutics Company Details 74 9.16.2 Huma Therapeutics Business Overview 74 9.16.3 Huma Therapeutics Digital Biomarker Introduction 74 9.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2020-2022) 74 9.16.5 Huma Therapeutics Recent Development 75 10 ANALYST'S VIEWPOINTS/CONCLUSIONS 76 11 APPENDIX 77 11.1 Research Methodology 77 11.1.1 Methodology/Research Approach 77 11.1.2 Data Source 80 11.2 Disclaimer 83 11.3 Author Details 83
SummaryMarket Analysis and Insights: Global Digital Biomarker Market Table of Contents1 REPORT OVERVIEW 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1 1.2.2 Passive Digital Biomarker 2 1.2.3 Active Digital Biomarker 2 1.3 Market by Application 3 1.3.1 Global Digital Biomarker Market Share by Application: 2017 VS 2021 VS 2028 3 1.3.2 Clinical Disease 4 1.3.3 Daily Health 4 1.4 Study Objectives 4 1.5 Years Considered 5 2 GLOBAL GROWTH TRENDS 6 2.1 Global Digital Biomarker Market Perspective (2017-2028) 6 2.2 Digital Biomarker Growth Trends by Region 7 2.2.1 Digital Biomarker Market Size by Region: 2017 VS 2021 VS 2028 7 2.2.2 Digital Biomarker Historic Market Size by Region (2017-2022) 8 2.2.3 Digital Biomarker Forecasted Market Size by Region (2023-2028) 9 2.3 Digital Biomarker Market Dynamics 9 2.3.1 Digital Biomarker Industry Trends 9 2.3.2 Digital Biomarker Market Drivers 10 2.3.3 Digital Biomarker Market Challenges and Restraints 11 3 COMPETITION LANDSCAPE BY KEY PLAYERS 12 3.1 Global Top Digital Biomarker Players by Revenue 12 3.1.1 Global Top Digital Biomarker Players by Revenue (2020-2022) 12 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2020-2022) 13 3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 14 3.3 Players Covered: Ranking by Digital Biomarker Revenue 16 3.4 Global Digital Biomarker Market Concentration Ratio 17 3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI) 17 3.4.2 Global Top 3 and Top 5 Companies by Digital Biomarker Revenue in 2021 18 3.5 Digital Biomarker Key Players Head office and Area Served 18 3.6 Date of Establishment in Digital Biomarker Market 19 3.7 Mergers & Acquisitions, Expansion Plans 19 4 DIGITAL BIOMARKER BREAKDOWN DATA BY TYPE 21 4.1 Global Digital Biomarker Historic Market Size by Type (2017-2022) 21 4.2 Global Digital Biomarker Forecasted Market Size by Type (2023-2028) 21 5 DIGITAL BIOMARKER BREAKDOWN DATA BY APPLICATION 23 5.1 Global Digital Biomarker Historic Market Size by Application (2017-2022) 23 5.2 Global Digital Biomarker Forecasted Market Size by Application (2023-2028) 23 6 NORTH AMERICA 25 6.1 North America Digital Biomarker Market Size (2017-2028) 25 6.2 North America Digital Biomarker Market Size by Type 25 6.2.1 North America Digital Biomarker Market Size by Type (2017-2022) 25 6.2.2 North America Digital Biomarker Market Size by Type (2023-2028) 25 6.2.3 North America Digital Biomarker Market Share by Type (2017-2028) 26 6.3 North America Digital Biomarker Market Size by Application 26 6.3.1 North America Digital Biomarker Market Size by Application (2017-2022) 26 6.3.2 North America Digital Biomarker Market Size by Application (2023-2028) 27 6.3.3 North America Digital Biomarker Market Share by Application (2017-2028) 27 6.4 North America Digital Biomarker Market Size by Country 27 6.4.1 North America Digital Biomarker Market Size by Country (2017-2022) 27 6.4.2 North America Digital Biomarker Market Share by Country (2023-2028) 28 6.4.3 United States 29 6.4.4 Canada 29 7 EUROPE 30 7.1 Europe Digital Biomarker Market Size (2017-2028) 30 7.2 Europe Digital Biomarker Market Size by Type 30 7.2.1 Europe Digital Biomarker Market Size by Type (2017-2022) 30 7.2.2 Europe Digital Biomarker Market Size by Type (2023-2028) 30 7.2.3 Europe Digital Biomarker Market Share by Type (2017-2028) 31 7.3 Europe Digital Biomarker Market Size by Application 31 7.3.1 Europe Digital Biomarker Market Size by Application (2017-2022) 31 7.3.2 Europe Digital Biomarker Market Size by Application (2023-2028) 32 7.3.3 Europe Digital Biomarker Market Share by Application (2017-2028) 32 7.4 Europe Digital Biomarker Market Size by Country 32 7.4.1 Europe Digital Biomarker Market Size by Country (2017-2022) 32 7.4.2 Europe Digital Biomarker Market Size by Country (2023-2028) 33 7.4.3 Germany 34 7.4.4 U.K. 34 7.4.5 France 35 7.4.6 Russia 35 7.4.7 Italy 36 8 ASIA-PACIFIC 37 8.1 Asia-Pacific Digital Biomarker Market Size (2017-2028) 37 8.2 Asia-Pacific Digital Biomarker Market Size by Type 37 8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2017-2022) 37 8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2023-2028) 37 8.2.3 Asia-Pacific Digital Biomarker Market Share by Type (2017-2028) 38 8.3 Asia-Pacific Digital Biomarker Market Size by Application 38 8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2017-2022) 38 8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2023-2028) 39 8.3.3 Asia-Pacific Digital Biomarker Market Share by Application (2017-2028) 39 8.4 Asia-Pacific Digital Biomarker Market Size by Region 39 8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2017-2022) 39 8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2023-2028) 40 8.4.3 China 41 8.4.4 Japan 41 8.4.5 South Korea 42 9 KEY PLAYERS PROFILES 43 9.1 Philips 43 9.1.1 Philips Company Details 43 9.1.2 Philips Business Overview 43 9.1.3 Philips Digital Biomarker Introduction 44 9.1.4 Philips Revenue in Digital Biomarker Business (2020-2022) 44 9.1.5 Philips Recent Development 45 9.2 Johnson & Johnson 46 9.2.1 Johnson & Johnson Company Details 46 9.2.2 Johnson & Johnson Business Overview 46 9.2.3 Johnson & Johnson Digital Biomarker Introduction 47 9.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2020-2022) 47 9.2.5 Johnson & Johnson Recent Development 47 9.3 Pfizer 48 9.3.1 Pfizer Company Details 48 9.3.2 Pfizer Business Overview 48 9.3.3 Pfizer Digital Biomarker Introduction 49 9.3.4 Pfizer Revenue in Digital Biomarker Business (2020-2022) 49 9.3.5 Pfizer Recent Development 49 9.4 GE Healthcare 50 9.4.1 GE Healthcare Company Details 50 9.4.2 GE Healthcare Business Overview 50 9.4.3 GE Healthcare Digital Biomarker Introduction 50 9.4.4 GE Healthcare Revenue in Digital Biomarker Business (2020-2022) 51 9.4.5 GE Healthcare Recent Development 51 9.5 Novartis 52 9.5.1 Novartis Company Details 52 9.5.2 Novartis Business Overview 52 9.5.3 Novartis Digital Biomarker Introduction 53 9.5.4 Novartis Revenue in Digital Biomarker Business (2020-2022) 53 9.5.5 Novartis Recent Development 53 9.6 Apple 54 9.6.1 Apple Company Details 54 9.6.2 Apple Business Overview 55 9.6.3 Apple Digital Biomarker Introduction 55 9.6.4 Apple Revenue in Digital Biomarker Business (2020-2022) 55 9.7 Sanofi 56 9.7.1 Sanofi Company Details 56 9.7.2 Sanofi Business Overview 56 9.7.3 Sanofi Digital Biomarker Introduction 57 9.7.4 Sanofi Revenue in Digital Biomarker Business (2020-2022) 57 9.8 GlaxoSmithKline 57 9.8.1 GlaxoSmithKline Company Details 57 9.8.2 GlaxoSmithKline Business Overview 58 9.8.3 GlaxoSmithKline Digital Biomarker Introduction 58 9.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2020-2022) 58 9.8.5 GlaxoSmithKline Recent Development 59 9.9 Bayer 59 9.9.1 Bayer Company Details 59 9.9.2 Bayer Business Overview 60 9.9.3 Bayer Digital Biomarker Introduction 60 9.9.4 Bayer Revenue in Digital Biomarker Business (2020-2022) 60 9.9.5 Bayer Recent Development 61 9.10 Merck 61 9.10.1 Merck Company Details 61 9.10.2 Merck Business Overview 62 9.10.3 Merck Digital Biomarker Introduction 62 9.10.4 Merck Revenue in Digital Biomarker Business (2020-2022) 62 9.10.5 Merck Recent Development 63 9.11 Abbott Laboratories 63 9.11.1 Abbott Laboratories Company Details 64 9.11.2 Abbott Laboratories Business Overview 64 9.11.3 Abbott Laboratories Digital Biomarker Introduction 65 9.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2020-2022) 65 9.11.5 Abbott Laboratories Recent Development 65 9.12 Asahi Kasei 66 9.12.1 Asahi Kasei Company Details 66 9.12.2 Asahi Kasei Business Overview 66 9.12.3 Asahi Kasei Digital Biomarker Introduction 67 9.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2020-2022) 67 9.12.5 Asahi Kasei Recent Development 67 9.13 Biogen 68 9.13.1 Biogen Company Details 68 9.13.2 Biogen Business Overview 68 9.13.3 Biogen Digital Biomarker Introduction 69 9.13.4 Biogen Revenue in Digital Biomarker Business (2020-2022) 69 9.14 Koneksa Health 69 9.14.1 Koneksa Health Company Details 70 9.14.2 Koneksa Health Business Overview 70 9.14.3 Koneksa Health Digital Biomarker Introduction 70 9.14.4 Koneksa Health Revenue in Digital Biomarker Business (2020-2022) 71 9.14.5 Koneksa Health Recent Development 71 9.15 Roche 72 9.15.1 Roche Company Details 72 9.15.2 Roche Business Overview 72 9.15.3 Roche Digital Biomarker Introduction 73 9.15.4 Roche Revenue in Digital Biomarker Business (2020-2022) 73 9.16 Huma Therapeutics 73 9.16.1 Huma Therapeutics Company Details 74 9.16.2 Huma Therapeutics Business Overview 74 9.16.3 Huma Therapeutics Digital Biomarker Introduction 74 9.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2020-2022) 74 9.16.5 Huma Therapeutics Recent Development 75 10 ANALYST'S VIEWPOINTS/CONCLUSIONS 76 11 APPENDIX 77 11.1 Research Methodology 77 11.1.1 Methodology/Research Approach 77 11.1.2 Data Source 80 11.2 Disclaimer 83 11.3 Author Details 83
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
QYResearch社のバイオ薬物分野での最新刊レポート
本レポートと同じKEY WORD(biomarker)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/25 10:26 155.25 円 163.23 円 198.36 円 |